BMJ Group: Extending Anti-Clotting Treatment Linked to Lower Rates of New Clots
November 14, 2025
November 14, 2025
LONDON, England, Nov. 14 (TNSjou) -- BMJ Group issued the following news release about their journal "The BMJ" on Nov. 13, 2025:
* * *
Extending anti-clotting treatment linked to lower rates of new clots
Continued use leads to overall "net clinical benefit" say researchers
*
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of . . .
* * *
Extending anti-clotting treatment linked to lower rates of new clots
Continued use leads to overall "net clinical benefit" say researchers
*
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of . . .
